ArticleJournal of gastrointestinal cancer2026

Four-Year Survival Outcomes of Personalized Total Neoadjuvant Therapy Versus Chemotherapy During the 'Wait Period' Versus Standard Chemoradiotherapy for Locally Advanced Rectal Cancer.

Sergei Bedrikovetski et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.